dc.contributor.author |
Kozlov M. |
|
dc.contributor.author |
Kleymenova A. |
|
dc.contributor.author |
Konduktorov K. |
|
dc.contributor.author |
Malikova A. |
|
dc.contributor.author |
Kochetkov S. |
|
dc.date.accessioned |
2018-09-18T20:02:08Z |
|
dc.date.available |
2018-09-18T20:02:08Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
0006-2979 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/135932 |
|
dc.description.abstract |
Acetylation of α-tubulin was studied in cultures of human hepatocytes under the influence of selective inhibitors of histone deacetylases HDAC6 and SIRT-2 - tubastatin A and 2-(3-phenethoxyphenylamino)benzamide, respectively. It was found that in hepatocyte cell line HepG2 acetylated α-tubulin is accumulated preferentially on inhibition of HDAC6 but not of SIRT-2. Under the same conditions, no acetylation of α-tubulin was observed in hepatocyte cell line Huh7. However, the inhibition of HDAC6 with tubastatin A led to hyperacetylation of α-tubulin and simultaneously to decrease in viral RNA concentration in hepatocyte cell line Huh7-luc/neo, which supports propagation of the full genome replicon of hepatitis C virus. The correlation between these two processes points to HDAC6 as a promising cellular target for therapy of hepatitis C. © 2014 Pleiades Publishing, Ltd. |
|
dc.relation.ispartofseries |
Biochemistry (Moscow) |
|
dc.subject |
acetylation of α-tubulin |
|
dc.subject |
HDAC6 and SIRT-2 |
|
dc.subject |
hepatitis C virus replicon |
|
dc.subject |
human hepatocytes |
|
dc.title |
Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
7 |
|
dc.relation.ispartofseries-volume |
79 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
637 |
|
dc.source.id |
SCOPUS00062979-2014-79-7-SID84906228124 |
|